<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04759989</url>
  </required_header>
  <id_info>
    <org_study_id>Fluid resuscitation</org_study_id>
    <nct_id>NCT04759989</nct_id>
  </id_info>
  <brief_title>Fluid Resuscitation in Septic Shock Patients With BMI Elevation</brief_title>
  <acronym>FRISSBE</acronym>
  <official_title>Fluid Resuscitation in Septic Shock Patients With BMI Elevation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atrium Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atrium Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the safety and feasibility of alternative fluid resuscitation strategies in obese&#xD;
      patients with septic shock.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early, goal-directed therapy with timely achievement of hemodynamic stability has been shown&#xD;
      to clearly improve outcomes in patients with septic shock. Although Surviving Sepsis Campaign&#xD;
      guidelines recommend a weight-based approach to initial fluid resuscitation (i.e. 30ml/kg),1&#xD;
      at present, there are no robust data to support whether dosing based on actual body weight or&#xD;
      an alternative correction formula (ideal body weight, adjusted body weight) is superior.&#xD;
&#xD;
      FRISSBE is a prospective, randomized, three-arm parallel-group pilot trial of alternative&#xD;
      resuscitation strategies for obese patients with septic shock, looking at feasibility and&#xD;
      safety of different weight-based approaches. Subject treatment assignment will not be&#xD;
      blinded. Data will be collected and analyzed on an intent-to-treat basis. The study will&#xD;
      enroll 60 subjects, with 20 subjects per treatment arm. Subjects will be randomized to&#xD;
      receive one of three weight-based initial fluid resuscitation strategies - 30cc/kg ideal body&#xD;
      weight (IBW), 30cc/kg adjusted body weight (AdjBW), or 30cc/kg actual body weight (ABW).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility1: fluid target</measure>
    <time_frame>3 hours</time_frame>
    <description>percentage of of patients with actual volume received within 10% of target fluid volume.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety-ventilation</measure>
    <time_frame>24 hours</time_frame>
    <description>Proportion of patients requiring invasive or noninvasive mechanical ventilation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety-vasopressors</measure>
    <time_frame>24 hours</time_frame>
    <description>proportion of patients requiring vasopressor administration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety-time to hemodynamic stability</measure>
    <time_frame>72 hours</time_frame>
    <description>time from randomization to map &gt;65 without use of vasopressors and no lactate &gt;2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exploratory: in-hospital all cause mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Proportion of patient in each group who experience death due to any cause during hospitalization up to 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exploratory: ICU length of stay</measure>
    <time_frame>28 days</time_frame>
    <description>number of consecutive midnights in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>feasibility2: recruitment rate</measure>
    <time_frame>study duration</time_frame>
    <description>proportion of patients enrolled out of patients screened to randomized through completion of study, an average of 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>feasibility3: time to randomization</measure>
    <time_frame>3 hours</time_frame>
    <description>median time from screening to randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exploratory: hospital length of stay</measure>
    <time_frame>28 days</time_frame>
    <description>number of midnights spent in hospital up to 28 days</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Sepsis</condition>
  <condition>Septic Shock</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>30cc/kg ideal body weight (IBW)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30cc/kg intravenous fluids based on the patients calculated ideal body weight will be administered when randomized to this arm&#xD;
Using Devine's formula. (men: 50kg + 2.3kg * (height(in) - 60); women: 45.5kg + 2.3kg * (height(in) - 60)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30cc/kg adjusted body weight (AdjBW)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30cc/kg intravenous fluids based on the patients calculated adjusted body weight will be administered when randomized to this arm&#xD;
Calculated by the following formula: AdjBW = IBW + 0.4(ABW - IBW).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30cc/kg actual body weight (ABW)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30cc/kg intravenous fluids based on the patients actual body weight will be administered when randomized to this arm&#xD;
Patients will receive an initial fluid bolus of 30 cc/kg of actual body weight</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Actual Body Weight Dosing</intervention_name>
    <description>30cc/kg initial bolus calculated using Actual Body Weight</description>
    <arm_group_label>30cc/kg actual body weight (ABW)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adjusted Body Weight Dosing</intervention_name>
    <description>30cc/kg initial bolus calculated using Adjusted Body Weight</description>
    <arm_group_label>30cc/kg adjusted body weight (AdjBW)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ideal Body Weight Dosing</intervention_name>
    <description>30cc/kg initial bolus calculated using Ideal Body Weight</description>
    <arm_group_label>30cc/kg ideal body weight (IBW)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  BMI &gt; 30&#xD;
&#xD;
          -  suspected infection, and either:&#xD;
&#xD;
               -  hypotension (a systolic blood pressure &lt; 90mmHg) or&#xD;
&#xD;
               -  blood lactate concentration &gt; 4mmol/L&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Primary diagnosis of acute cerebral vascular event&#xD;
&#xD;
          -  Acute coronary syndrome&#xD;
&#xD;
          -  Acute pulmonary edema&#xD;
&#xD;
          -  Status asthmaticus&#xD;
&#xD;
          -  Major cardiac arrhythmia&#xD;
&#xD;
          -  Active gastrointestinal hemorrhage&#xD;
&#xD;
          -  Seizures&#xD;
&#xD;
          -  Drug overdose&#xD;
&#xD;
          -  Burns or trauma&#xD;
&#xD;
          -  Requirement for immediate surgery&#xD;
&#xD;
          -  CD4&lt;50/mm3&#xD;
&#xD;
          -  Do-not-resuscitate order status&#xD;
&#xD;
          -  Transferred from another hospital&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brice Taylor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atrium Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brice Taylor, MD</last_name>
    <phone>8139447050</phone>
    <email>brice.taylor@atriumhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brice Taylor, MD</last_name>
      <phone>813-944-7050</phone>
      <email>brice.taylor@atriumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Michael Runyon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Taylor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255.</citation>
    <PMID>28098591</PMID>
  </reference>
  <reference>
    <citation>Wacharasint P, Boyd JH, Russell JA, Walley KR. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care. 2013 Jun 20;17(3):R122. doi: 10.1186/cc12794.</citation>
    <PMID>23786836</PMID>
  </reference>
  <reference>
    <citation>Arabi YM, Dara SI, Tamim HM, Rishu AH, Bouchama A, Khedr MK, Feinstein D, Parrillo JE, Wood KE, Keenan SP, Zanotti S, Martinka G, Kumar A, Kumar A; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013 Apr 17;17(2):R72. doi: 10.1186/cc12680.</citation>
    <PMID>23594407</PMID>
  </reference>
  <reference>
    <citation>Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011 Feb;39(2):259-65. doi: 10.1097/CCM.0b013e3181feeb15.</citation>
    <PMID>20975548</PMID>
  </reference>
  <reference>
    <citation>Marik PE, Linde-Zwirble WT, Bittner EA, Sahatjian J, Hansell D. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med. 2017 May;43(5):625-632. doi: 10.1007/s00134-016-4675-y. Epub 2017 Jan 27.</citation>
    <PMID>28130687</PMID>
  </reference>
  <reference>
    <citation>Taylor SP, Karvetski CH, Templin MA, Heffner AC, Taylor BT. Initial fluid resuscitation following adjusted body weight dosing is associated with improved mortality in obese patients with suspected septic shock. J Crit Care. 2018 Feb;43:7-12. doi: 10.1016/j.jcrc.2017.08.025. Epub 2017 Aug 15.</citation>
    <PMID>28823951</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 10, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atrium Health</investigator_affiliation>
    <investigator_full_name>Brice Taylor</investigator_full_name>
    <investigator_title>Principal investigator, Pulmonary and Critical Care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

